Targeted Drug Delivery
DNA nanobots excel at delivering drugs directly to cancerous tumors, bypassing the body’s healthy cells. Unlike systemic treatments, which flood the entire body with medication and often cause severe side effects, nanobots release their payload only at the targeted site. For example, a DNA nanobot can be programmed to open and release chemotherapy agents precisely when it detects a tumor marker. This targeted approach maximizes treatment impact while minimizing collateral damage to healthy tissues.